Cure8 research brief
Why This Matters
Fatigue greatly affects quality of life for people with IBD even in remission; if effective and scalable, a mobile CBT program could offer accessible symptom support. The trial will also examine engagement factors important for real-world use.
Who Should Pay Attention
Adults with Crohn’s disease or ulcerative colitis experiencing fatigue; clinicians and IBD care teams exploring nonpharmacologic/supportive interventions; researchers in digital health and symptom management.
Study Snapshot
What To Know
This report is a trial protocol/abstract from JMIR Research Protocols describing an open-label, waitlist-controlled randomized trial of a 7-week cognitive behavioral therapy–based mobile intervention plus support messages for adults with IBD in remission who have at least mild fatigue.
Participants were stratified by disease type, sex, and baseline fatigue; the primary outcome is fatigue measured by FACIT-F and a secondary outcome is IBD self-efficacy (IBD-SES13). Recruitment enrolled 351 randomized participants; follow-up is ongoing and outcome results are not yet available.
The study focuses on engagement with the app and the intervention’s potential effect on fatigue; results are expected to be published after follow-up completes in 2027.
Keep In Mind
This record is an abstract/protocol (structured content depth: abstract). It describes study design and recruitment but does not report outcome results—results will be published after follow-up completion. Interpret findings only after the full trial results are available.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.